Skip to main content
. 2011 Sep 28;2012:808724. doi: 10.1155/2012/808724

Figure 3.

Figure 3

Nitric oxide generation kinetics in CD4+ and CD8+ cells following activation in healthy controls (n = 9) and ankylosing spondylitis patients before infliximab (IFX) therapy (n = 13) then 2 and 6 weeks after initiation of IFX (n = 11 and 8, resp.). *P < 0.05 AUC: area under the curve. For details of IFX therapy, see text.